CAS: 1610353-18-8 - Immunoglobulin G2, anti-(human interleukin 23) (human monoclonal MEDI2070 heavy chain), disulfide with human monoclonal MEDI2070 λ-chain, dimer
Formula:Unspecified
- Synonyms:
- MEDI 2070
- AMG 139
- Immunoglobulin G2, anti-(human interleukin 23) (human monoclonal MEDI2070 heavy chain), disulfide with human monoclonal MEDI2070 λ-chain, dimer
- Immunoglobulin G2-lambda, anti-(human interleukin-23 (IL-23)); human monoclonal antibody:γ2 heavy chain (1-450) [human VH (Homo sapiens IGHV3-33*01 (99%) ?(IGHD)-IGHJ3*02) [8.8.17] (1-124) -Homo sapiens IGHG2*01 (125-450)] (138-216′)-disulfide with lambda light chain (1′-217′) [human V-LAMBDA (Homo sapiens IGLV1-40*01 (96%) -IGLJ3*02 (92%)) [9.3.11] (1′-111′) -Homo sapiens IGLC2*01 (112′-217′)], dimer (226-226′′:227227′′:230-230′′:233-233′′)-tetrakisdisulfide
- Brazikumab
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Brazikumab REF: TM-T76934CAS: 1610353-18-8 | - - - | 233.00 €~2,623.00 € | Mon 21 Oct 24 |
 | Brazikumab REF: 3D-CLA1456CAS: 1610353-18-8 | - - - | To inquire | Tue 29 Oct 24 |
Brazikumab
CAS:1610353-18-8
Brazikumab (AMG 139), a human IgG2 monoclonal antibody, targets IL-23 p19 subunit, KD 0.138 nM, …
Color and Shape:
Solid
Ref: TM-T76934
| 1mg | 233.00 € | ||
| 5mg | 607.00 € | ||
| 10mg | 928.00 € | ||
| 25mg | 1,439.00 € | ||
| 50mg | 1,862.00 € | ||
| 100mg | 2,623.00 € |
Estimated delivery in United States, on Monday 21 Oct 2024
Brazikumab
CAS:1610353-18-8
Anti-IL23 human monoclonal antibody; used as a treatment of Crohn's disease
Ref: 3D-CLA1456
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 29 Oct 2024
